IS3008B - Stöðgandi lausnir fyrir prótín og peptíð - Google Patents

Stöðgandi lausnir fyrir prótín og peptíð

Info

Publication number
IS3008B
IS3008B IS050080A IS050080A IS3008B IS 3008 B IS3008 B IS 3008B IS 050080 A IS050080 A IS 050080A IS 050080 A IS050080 A IS 050080A IS 3008 B IS3008 B IS 3008B
Authority
IS
Iceland
Prior art keywords
peptide
protein stabilizing
stabilizing formulation
formulation
protein
Prior art date
Application number
IS050080A
Other languages
English (en)
Inventor
Sveinbjörn Gizurarson
Sigurðsson Stefán Jón
Original Assignee
Calor ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calor ehf filed Critical Calor ehf
Priority to IS050080A priority Critical patent/IS3008B/is
Priority to US15/310,287 priority patent/US9968648B2/en
Priority to PCT/IS2015/050009 priority patent/WO2015173839A1/en
Publication of IS3008B publication Critical patent/IS3008B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
IS050080A 2014-05-14 2014-05-14 Stöðgandi lausnir fyrir prótín og peptíð IS3008B (is)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IS050080A IS3008B (is) 2014-05-14 2014-05-14 Stöðgandi lausnir fyrir prótín og peptíð
US15/310,287 US9968648B2 (en) 2014-05-14 2015-05-15 Peptide or protein stabilizing formulation
PCT/IS2015/050009 WO2015173839A1 (en) 2014-05-14 2015-05-15 A peptide or protein stabilizing formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS050080A IS3008B (is) 2014-05-14 2014-05-14 Stöðgandi lausnir fyrir prótín og peptíð

Publications (1)

Publication Number Publication Date
IS3008B true IS3008B (is) 2018-12-15

Family

ID=53502720

Family Applications (1)

Application Number Title Priority Date Filing Date
IS050080A IS3008B (is) 2014-05-14 2014-05-14 Stöðgandi lausnir fyrir prótín og peptíð

Country Status (3)

Country Link
US (1) US9968648B2 (is)
IS (1) IS3008B (is)
WO (1) WO2015173839A1 (is)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107361360A (zh) * 2017-07-24 2017-11-21 冯纪敏 一种组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153689A (en) * 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
EP0852951A1 (de) * 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
JP2007525442A (ja) 2003-03-05 2007-09-06 ピーアール ファーマシューティカルズ，インコーポレイテッド オキシトシン制御放出処方物およびオキシトシン制御放出処方物を使用する方法
KR20050104152A (ko) 2004-04-28 2005-11-02 최승호 경구용 약물의 흡수를 증진하는 약제학적 조성물
JP5068167B2 (ja) 2005-06-10 2012-11-07 中外製薬株式会社 メグルミンを含有するタンパク質製剤の安定化剤、およびその利用
EP1902705A1 (en) 2006-09-22 2008-03-26 Pharmatex Italia Srl Injectable pharmaceutical nimesulide solutions
EP2161030A1 (en) 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
PL2550018T3 (pl) * 2010-03-22 2019-08-30 F.Hoffmann-La Roche Ag Kompozycje i sposoby użyteczne do stabilizowania preparatów zawierających białko
JP6220789B2 (ja) 2011-10-18 2017-10-25 コヒラス・バイオサイエンシズ・インコーポレイテッド 糖およびポリオールの組合せによって安定化されたエタネルセプト製剤
DK2804634T3 (da) * 2012-01-19 2019-11-04 Merck Millipore Ltd Kromatografiske medier til oplagring og indgivelse af terapeutiske biologiske stoffer og små molekyler

Also Published As

Publication number Publication date
US9968648B2 (en) 2018-05-15
WO2015173839A1 (en) 2015-11-19
US20170157201A1 (en) 2017-06-08

Similar Documents

Publication Publication Date Title
GB201520559D0 (en) Peptides
GB201607534D0 (en) Peptides
GB201520536D0 (en) Peptides
GB201604468D0 (en) Peptides
GB201520545D0 (en) Peptides
GB201520546D0 (en) Peptides
GB201520562D0 (en) Peptides
GB201520550D0 (en) Peptides
GB201520543D0 (en) Peptides
GB201520544D0 (en) Peptides
GB201520567D0 (en) Peptides
GB201520539D0 (en) Peptides
GB201520563D0 (en) Peptides
GB201520541D0 (en) Peptides
GB201405891D0 (en) Modified antimicrobial peptides
GB201612150D0 (en) Modified peptide
GB201607535D0 (en) Peptides
GB201520564D0 (en) Peptides
GB201520566D0 (en) Peptides
GB201520548D0 (en) Peptides
GB201520558D0 (en) Peptides
GB201520557D0 (en) Peptides
GB201520568D0 (en) Peptides
GB201520570D0 (en) Peptides
GB201520542D0 (en) Peptides